Radiant Innovation Inc. (TPEX: 3373)
Taiwan
· Delayed Price · Currency is TWD
23.00
-0.55 (-2.34%)
Dec 31, 2024, 1:30 PM CST
Radiant Innovation Revenue
Radiant Innovation had revenue of 106.91M TWD in the quarter ending September 30, 2024, with 12.31% growth. This brings the company's revenue in the last twelve months to 404.26M, down -9.02% year-over-year. In the year 2023, Radiant Innovation had annual revenue of 418.50M, down -25.87%.
Revenue (ttm)
404.26M
Revenue Growth
-9.02%
P/S Ratio
2.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
961.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 418.50M | -146.06M | -25.87% |
Dec 31, 2022 | 564.56M | -420.49M | -42.69% |
Dec 31, 2021 | 985.04M | -1.63B | -62.36% |
Dec 31, 2020 | 2.62B | 1.83B | 233.38% |
Dec 31, 2019 | 784.90M | -30.28M | -3.71% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Lotus Pharmaceutical | 17.59B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |
TaiMed Biologics | 622.61M |